INTRODUCTION
Hyperreactio luteinalis (HL) is the second most common ovarian disorder of pregnancy after luteoma of pregnancy and is characterized by bilateral cystic enlargement of ovaries (1) . The ovaries may be moderately to massively enlarged by multiple luteinized follicle cysts, secondary to stimulation with hCG and gonadotropins (2) . HL is most often associated with gestational trophoblastic disease, fetal hydrops, and multiple gestations, but this benign condition is occasionally observed during normal pregnancy with normal hCG levels. An iatrogenic form occurs in a variable proportion of women undergoing ovulation induction. HL is managed conservatively with preservation of the affected ovaries. Surgical intervention is usually performed only to remove infarcted tissue, control hemorrhage, or reduce ovarian size in patients with associated virilization. In rare cases, the cysts persist and are subsequently biopsied (3) .
This report describes an unusual case of bilateral serous cystadenofibromas clinically mimicking bilateral persistent bilateral hyperactive luteinalis during a normal singleton pregnancy achieved by controlled ovarian hyperstimulation and in vitro fertilization. These ovarian cysts developed during the pregnancy and partially regressed postpartum. Persistent enlargement at 2-year follow-up prompted surgical intervention.
CASE REPORT
A 3 l-year-old nulligravida female presented with a complaint of 2.5 years of infertility. Her initial infertility evaluation included a normal transvaginal ultrasound, laparoscopy, and hysteroscopy. The semen analysis was also normal and she was found to have idiopathic infertility.
The patient elected to undergo ovulation induction and in vitro fertilization (IVF) without any prior cycles of COH. Following her third cycle of IVF, she became pregnant. Transvaginal ultrasound done 26 days posttransfer documented a singleton intrauterine pregnancy with fetal cardiac activity. No abnormal adnexal masses or free fluid was noted.
A follow-up transvaginal ultrasound scan by her obstetrician at 5 weeks posttransfer revealed hyperstimulated ovaries measuring approximately 7 cm. During the pregnancy, larger cystic ovaries developed, from 14.4 x 12.5 and 11.1 × 8.6 cm at 17 weeks to 22.8 X 16.2 and 14.4 X 11.7 cm at 22 weeks, respectively.
The patient had a normal spontaneous vaginal delivery of a 3595-g female infant at 39 weeks' gestation. No maternal or fetal virilization was noted at birth.
Her enlarged cystic ovaries persisted and were noted at her 1-tnonth postpartum follow-up exam. Ultrasound results revealed the right ovary to be 19.2 x 17.9 X 13.3 cm and the left ovary to be 12.4 X 11.9 x 8.6 cm. She was followed with four ultrasound exams during her 10-month follow-up, while her condition was noted to improve. Her I 0-month postpartum scan revealed a fight ovary measuring 7.0 x 3.4 x 5.3 cm containing a thin-walled sonolucent structure measuring 4.3 × 4.5 X 4.9 cm with low-level echoes. The left ovary measured 7.0 × 3.3 × 5.1 cm and also contained a thin-walled sonolucent structure measuring 4.6 x 2.6 X 3.3 cm with clear fluid. The patient subsequently moved to another state and was lost to follow-up.
Two years later the patient desired a second pregnancy and presented for IVF at her local center. During her initial evaluation, transvaginal ultrasound revealed bilateral enlarged ovaries containing multiple cysts measuring up to 2.3 cm in size and IVF was deferred. The right and left ovaries were approximately 6 cm and contained several cysts. The cysts in both ovaries were aspirated, and the aspirate was cytologically negative for malignancy. A CA-125 was 35 U/ml at this time.
Within 3 months, the cysts recurred. The patient's CA-125 level increased from 35 to 107 U/ml over this time period. She was taken to surgery, where a unilateral right oophorectomy, left ovarian biopsy, and cyst aspiration were performed laparoscopically.
Histological evaluation of numerous sections from both ovaries revealed (i) scattered follicle and corpus luteum cysts, (ii) bilateral serous cystadenofibromas and multiple serous inclusion glands and cysts, and (iii) no epithelial proliferation or cytologic atypia. Figure 1 illustrates representative sections from the ovary. The cytological evaluation of the peritoneal fluid was negative for malignancy.
DISCUSSION
A variety of cystic ovarian conditions may develop during pregnancy. Most of these conditions represent exaggerated functional cysts, hyperr~actio luteinalis, or pregnancy luteoma (I). Although uncommon, benign, low-malignant potential, and malignant neoplastic disorders may also first come to clinical attention during pregnancy. In most instances, serum marker studies, imaging procedures, and the clinical setting serve to distinguish between those conditions that require immediate further study and those that can be managed in a conservative fashion. The recommended approach for a pregnant patient with the sonographic findings of bilateral multilocular ovarian cysts is primarily noninterventional because the cysts in HL regress once pregnancy ends (2, 4, 5) . Mistaken diagnoses resulting in excessive surgery have been reported in up to 36% of HL cases (2) . Of these mistaken diagnoses, ovarian cystadenoma is reported to be the most common (2). Our patient is unusual in that she had a mistaken clinical and sonographic diagnosis of HL for 2 years before the correct diagnosis of bilateral cystadenomas was obtained. Diagnosis was delayed in part because the ovarian cysts partially regressed on postpartum followup. Lutein-like stromal changes have been described in association with cystadenomas during pregnancy and it is likely that the partial regression in this case was due to regression of similar stromal changes postpartum (6) . This case demonstrates that the clinical and sonographic features of HL are not entirely specific and that patients who develop enlarged ovarian cysts during pregnancy should be carefully followed with serial serum marker levels and ultrasound to ensure complete regression during the peurperium.
The development of bilateral serous cystadenomas and multiple surface epithelial inclusion cysts following controlled ovarian stimulation and in vitro fertilization is of interest given the recent literature concerning the possible increased risk of ovarian tumors of low malignant potential and invasive carcinoma in women treated with fertility medications (7-9). It has been proposed that these surface epithelial inclusion glands and cysts arise via a process of cortical invagination from the surface epithelium and are likely the site of origin of most common epithelial tumors of the ovary (I0). An increased number of these inclusion glands have been identified in the contralateral ovary in patients with ovarian cancer compared with controls (11) .
Enlarged cystic ovaries discovered during pregnancy may require surgical intervention due to pain, infarction, or hemorrhage. In these instances, efforts should be made to preserve ovarian function once the diagnosis of HL is established (4). In the absence of a definitive tissue diagnosis, all patients with enlarged cystic ovaries and a presumptive clinical diagnosis of pregnancy luteoma or HL should be carefully followed postpartum to ensure complete regression. The natural history of HL is postpartum regression, typically within the first 4 to 8 weeks (12) . Rarely, regression is not complete until 6 months postpartum (12) . Serum CA-125 levels are not reliable in distinguishing benign, physiologic, and neoplastic conditions (13, 14) .
SUMMARY
We report a case of bilateral serous cystadenofibromas clinically simulating hyperreactio luteinalis during a normal pregnancy resulting from controlled ovarian stimulation and in vitro fertilization. Incomplete regression at 2-year follow-up prompted surgical intervention. This case demonstrates that the clinical and sonographic features that have been associated with hyperreactio luteinalis are not specific for this condition and emphasizes the need for close clinical followup in all presumptive cases for which a histologic diagnosis has not been established. 
INTRODUCTION
Various culture vessels are used in the performance of in vitro fertilization (IVF; organ culture dishes, petri dishes, tissue culture tubes), while varying volumes of culture media (microdrops to 3.0 ml) are used for oocyte insemination (1) . The choice of which culture vessel and insemination medium volume are used is controlled, at least in part, by practical aspects. For example, the amount of time saved and the reduced risk of losing or damaging the oocytes/embryos are two advantages of using microdrops in a petri dish versus tissue culture tubes. However, these advantages may be nullified if the outcome (i.e., fertilization, embryo quality, decreased incidence of polyploidy, etc.) favors the tissue culture tube. Preliminary results (2) indicate that inseminating and culturing in microdrops and tissue culture tubes demonstrate similar outcomes, but the data are limited in the number of oocytes evaluated and lack some of the stringency of methodology that would help to discern a true difference between oocyte insemination and culture in the two culture vessels.
The purpose of this study is to compare results of fertilization and development of human oocytes/ embryos when insemination and culture are carried out in tissue culture tubes or microdrops which contained an equivalent number of motile sperm.
MATERIALS AND METHODS
Techniques used for controlled ovarian hyperstimulation and transvaginal oocyte retrieval have been described in detail elsewhere. (3) A total of 733 oocytes from 54 IVF patients was included in this study. Each patient underwent a single IVF cycle. The patient population included 21 patients (39%) with endometriosis as their primary diagnosis, 14 patients (26%) with tubal factor, 7 patients (13%) with ovulatory dysfunction, 3 patients (6%) with male factor, 3 patients (6%) with uterine factor, 3 patients (6%) with pelvic adhesions, 2 patients (4%) with recurrent ectopics, and i patient (2%) with unexplained infertility. The average age of the female patients was 33 years old, with a range of 24 to 46 years.
Oocyte culture techniques performed routinely in the Assisted Reproductive Technology (ART) Laboratory at the Greenville Hospital System were used in this study. Oocytes in the tissue culture tubes were exposed to 100,000 motile sperm/tube, whereas the oocytes in the microdrops were exposed to 5000 motile sperm/drop. (A total of 5000 sperm per 50 ~1 is equivalent to
